|1.||Salimath, Bharathi P: 13 articles (09/2013 - 10/2002)|
|2.||Matsui-Yuasa, Isao: 7 articles (05/2010 - 02/2002)|
|3.||Kennedy, David Opare: 7 articles (05/2010 - 02/2002)|
|4.||Kojima-Yuasa, Akiko: 6 articles (05/2010 - 06/2003)|
|5.||Hoffmann, E K: 6 articles (09/2002 - 01/2000)|
|6.||Tanaka, Hiroshi: 5 articles (01/2012 - 04/2004)|
|7.||Kageyama, Katsuhiro: 5 articles (01/2012 - 04/2004)|
|8.||Miwa, Nobuhiko: 5 articles (01/2012 - 04/2004)|
|9.||Belakavadi, Madesh: 5 articles (01/2007 - 10/2002)|
|10.||Miwa, N: 4 articles (06/2015 - 01/2000)|
02/20/2002 - "To further evaluate the efficacy of the anticancer activity of 1'-acetoxychavicol acetate (ACA), this study investigates the underlying mechanisms by which ACA induces death of Ehrlich ascites tumor cells. "
12/01/2000 - "The efficacy of the antitumor activity of 1'-acetoxychavicol acetate (ACA), reported to be a suppressor of chemically induced carcinogenesis, was evaluated in Ehrlich ascites tumor cells. "
12/01/2000 - "Apoptosis induced by 1'-acetoxychavicol acetate in Ehrlich ascites tumor cells is associated with modulation of polyamine metabolism and caspase-3 activation."
05/14/2010 - "Comparison of glutathione reductase activity and the intracellular glutathione reducing effects of 13 derivatives of 1'-acetoxychavicol acetate in Ehrlich ascites tumor cells."
01/01/2009 - "The effect of 1'-acetoxychavicol acetate (ACA), an anticarcinogenic compound naturally obtained from rhizomes and seeds of South East Asia plants, on the intracellular concentration of glutathione and the activities of enzymes related to glutathione metabolism was studied in Ehrlich ascites tumor cells. "
|2.||Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/01/2009 - "Ehrlich ascites tumor-bearing mice were divided into three HSS groups (25, 50 and 100 mg/kg, i.v., respectively), cyclophosphamide (10 mg i.p.) and control group. "
01/01/1975 - "Cells of Ehrlich ascites tumor survived after cyclophosphamide injection showed no multiplication during 48 hours. "
08/15/1966 - "[On the course of activation of cyclophosphamide in man and the test of the cytostatic active form on Ehrlich ascites tumor cells]."
05/01/1988 - "In the chemotherapy experiment, female ICR mice each received an inoculum of 1 x 10(6) cells of Ehrlich ascites tumor ip followed by 2 ip injections of cyclophosphamide 36 and 37 hr later (2.4 mg/mouse for the 1st injection, and 1.0 mg/mouse for the 2nd injection). "
09/01/1983 - "Recently, we developed several antineoplastic PGs which showed IC50 value less than 0.3 microgram/ml against L1210 leukemia cells, and these compounds also showed antitumor activity against Ehrlich ascites tumor in vivo comparable to that of cyclophosphamide. "
|3.||Etoposide (VP 16)FDA LinkGeneric
04/01/2012 - "The biodistribution studies carried out on Ehrlich ascites tumor-bearing Balb/C mice confirmed higher accumulation of etoposide-loaded micellar formulation at tumor site compared to plain etoposide due to enhanced permeability and retention effect."
01/01/2005 - "The purpose of the present studies was to investigate the therapeutic effects of etoposide and 2-DG in Ehrlich ascites tumor (EAT) bearing mice, grown as solid tumor as well as in the ascites form. "
01/01/2005 - "The glycolytic inhibitor 2-deoxy-D-glucose enhances the efficacy of etoposide in ehrlich ascites tumor-bearing mice."
01/01/1996 - "The L1210-bearing mice appeared to obtain a larger increase in life span from the etoposide and ICRF-187 combination as compared with etoposide alone, whereas this was not the case in mice inoculated with Ehrlich ascites tumor cells. "
01/01/1994 - "In therapy experiments on mice inoculated with Ehrlich ascites tumor cells, aclarubicin given at 6 mg/kg roughly halved the increase in median life span induced by VP-16 at doses ranging from 22 to 33 mg/kg. An attempt to determine a more favorable combination of VP-16 and aclarubicin by increasing VP-16 doses failed, as the two drugs were always less effective than VP-16 alone. "
05/25/1979 - "An improved procedure for the isolation of interferons produced by mouse Ehrlich ascites tumor cells infected with Newcastle disease virus provides interferons of three size classes (33,000, 26,000, and 20,000 daltons) with specific activities between 2 and 3 x 10(9) units/mg of protein and a yield of 11 to 20%. "
05/01/1995 - "A single species of 100 kD protein was isolated, and its N-terminal sequence analysis suggested that mouse Ehrlich ascites tumor cell-derived interferon-induced 100 kD protein is a novel protein."
05/01/1995 - "Purification and N-terminal sequence of a novel interferon-induced 100 kD protein secreted by mouse Ehrlich ascites tumor cells."
09/01/1988 - "The 203 mRNAs are induced about 15-fold in interferon-treated Ehrlich ascites tumor cells."
05/01/1988 - "Interferon induces cell fusion and the formation of multinuclear cells in a culture of Ehrlich ascites tumor cells."
|5.||Deoxyglucose (2 Deoxy D glucose)IBA
01/01/2014 - "Enhanced antitumor immunity contributes to the radio-sensitization of ehrlich ascites tumor by the glycolytic inhibitor 2-deoxy-D-glucose in mice."
01/01/1968 - "Oxydative phosphorylation of mitochondria of Ehrlich ascites tumor cells and normal rat liver in the presence of 2-deoxy-D-glucose."
06/01/1958 - "Inhibition of anaerobic glycolysis in Ehrlich ascites tumor cells by 2-deoxy-D-glucose."
01/01/2005 - "The glycolytic inhibitor 2-deoxy-D-glucose enhances the efficacy of etoposide in ehrlich ascites tumor-bearing mice."
12/01/2004 - "Radiosensitization of murine Ehrlich ascites tumor by a combination of 2-deoxy-D-glucose and 6-aminonicotinamide."
05/01/1963 - "[Preliminary study on the specific antigen of Ehrlich ascites tumor]."
05/01/1974 - "When Ehrlich ascites tumor cells fused with UV-inactivated HVJ (Sendai virus) were cultured, the viral envelope antigens, which had been integrated at random into the cell membranes, accumulated at one site on the fused cell. "
04/01/1972 - "The Ehrlich ascites tumor, which has been subjected to prolonged selection for growth in allogeneic hosts, possesses powerful mechanisms for the suppression of antigens normally found on the cell surface. "
08/25/1964 - "FLUOROCARBON TREATMENT FOR PURIFICATION OF ANTIGENS OF EHRLICH ASCITES TUMOR CELLS."
12/01/1963 - "PRESENCE OF VIRAL ANTIGEN IN INCLUSION BODIES FORMED IN EHRLICH ASCITES TUMOR CELLS INFECTED WITH NEWCASTLE DISEASE VIRUS."
|7.||Hydrocortisone (Cortisol)FDA LinkGeneric
07/01/1992 - "Differential surface structures of invasive and non-invasive Ehrlich ascites tumor cell lines with special reference to the effect of hydrocortisone treatment."
05/01/1970 - "Survival time of mice bearing Ehrlich ascites tumor, with special reference to the effect of hydrocortisone administration."
11/01/1962 - "Effect of hydrocortisone on Ehrlich ascites tumor."
09/01/1992 - "2) Development of lung metastasis of blood-borne Ehrlich ascites tumor cells was facilitated in mice by hydrocortisone pretreatment--a substitute for surgical stress conditioning. "
04/01/1975 - "Enhancing effect of hydrocortisone on hematogenous metastasis of Ehrlich ascites tumor in mice."
01/01/1983 - "Synthesis in vitro of novel nucleic-acid-like polymers of Ehrlich ascites tumor cells."
05/14/2010 - "In addition, PolyDOC uptake in Ehrlich Ascites Tumor (EAT) tumor bearing mice was larger at each time point compared to DS, making such a polymer vesicle formulation an efficient drug nanocarrier for improved DOC cancer therapy."
01/24/1983 - "In vitro formation of different tubulin polymers from purified tubulin of Ehrlich ascites tumor cells."
01/01/1983 - "1. Novel nucleic-acid-like polymers containing glucose, glucose 'nucleic acid', were isolated from cytoplasmic particles of Ehrlich ascites tumor cells. "
01/01/1983 - "Isolation and characterization of nucleic-acid-like polymers containing glucose from Ehrlich ascites tumor cells."
|9.||4-Chloromercuribenzenesulfonate (4 Chloromercuribenzenesulfonate)IBA
02/06/1979 - "I. Scanning and transmission electron microscopy of cell surface changes following p-chloromercuribenzene sulfonic acid (pcmbs)-induced injury of Ehrlich ascites tumor cells."
10/01/1982 - "In order to ascertain the significance of the hydrophobic region in the carrier protein responsible for the D-leucine transport reported previously, the effects of p-chloromercuribenzene sulfonate (PCMBS) were investigated on the transport of D- and L-leucines in Ehrlich ascites tumor cells. "
08/01/1983 - "The possible protective effects of 30 and 180 mM mannitol added to the extracellular medium were studied in Ehrlich ascites tumor cells (EATC) injured by the nonpenetrating mercurial p-chloromercuribenzenesulfonic acid (PCMBS) or by anoxia. "
08/01/1983 - "Studies on the modification of the cellular response to injury: effect of mannitol on Ehrlich ascites tumor cells following injury by anoxia or p-chloromercuribenzenesulfonic acid (PCMBS)."
|10.||Paclitaxel (Taxol)FDA LinkGeneric
12/09/2015 - "Administration of PSMAC-PTX NPs showed significant tumor growth inhibition with improved apoptosis effects in vivo on Ehrlich Ascites Tumor (EAT)-bearing BALB/c syngeneic mice in comparison with Taxol, without showing any cytotoxicity. "
03/01/2007 - "In this study the antiproliferative effects of Paclitaxel (PAC), Epirubicin (EPI) and Tamoxifen (TAM) on growth kinetics of Ehrlich Ascites Tumor (EAT) cells were examined in culture. "
03/01/2007 - "Evaluation of the effect of paclitaxel, epirubicin and tamoxifen by cell kinetics parameters in estrogen-receptor-positive ehrlich ascites tumor (eat) cells growing in vitro."
12/01/1966 - "Acquired immunity to Ehrlich ascites tumor in mice after treatment with fresh or sonized tumor cells at various ages."
01/01/1989 - "An autoradiographic study was performed on binucleate and mitotic cells in the Ehrlich ascites tumor (EAT) untreated and after treatment with 5-fluorouracil (FU). "
04/01/1971 - "[The time dependent, electronically measured change in volume frequency distribution of Ehrlich ascites tumor cells after treatment with alkylating cytostatics in vivo]."
10/01/1961 - "Increase in dry mass of Ehrlich ascites tumor cells after treatment with nitrogen mustard."
01/01/1982 - "Development of necroses, virus activation and giant cell formation after treatment of Ehrlich ascites tumor with metallocene dichlorides."
|2.||Transplantation (Transplant Recipients)
10/01/2014 - "We studied structural changes in the prostate gland, thymus, and lymph nodes in CBA mice after transplantation of Ehrlich ascites tumor cells into the prostate gland. "
02/01/2001 - "Effects of the green algae Chlorella vulgaris on the response of the host hematopoietic system to intraperitoneal ehrlich ascites tumor transplantation in mice."
08/01/1981 - "The activity of the beta-form markedly increased following intraperitoneal transplantation of Ehrlich ascites tumor cells, whereas the activity of the alpha-form did not change so strikingly. "
04/01/1978 - "Effects of Ehrlich ascites tumor transplantation in mice on the distribution of cells capable of forming hemopoietic colonies in vitro."
06/01/1969 - "Antitumor factors of regional lymph node cells in the transplantation of Ehrlich ascites tumor cells. "
01/01/2002 - "To understand the relationship between the location of organelles and cellular function, we examined the dynamic state of cytoplasmic organelles and cytoskeleton in polynuclear Ehrlich ascites tumor (EAT) cells fused with hemagglutinating virus of Japan (HVJ; Sendai virus) by confocal laser scanning microscopy. "
01/01/1984 - "[Effect of low-intensity laser radiation on the kinetics of cell proliferation in Ehrlich ascites tumor]."
12/01/1980 - "[Kinetic changes in the cellular proliferation of Ehrlich ascites tumor as affected by low-intensity laser radiation]."
04/01/1972 - "[Ultrastructural changes caused by laser beams in Ehrlich ascites tumor cells]."
01/01/1971 - "[Ultrastructural changes in Ehrlich ascites tumor cells following laser irradiation]."
03/01/1961 - "Studies on ameboid motility of Ehrlich ascites tumor cells in a transplant generation."
03/01/1966 - "Comparison of the survival of skin grafts from normal mice and mice with Ehrlich ascites tumor."
01/01/1966 - "Growth of subcutaneous grafts of some clones of Ehrlich ascites tumor in mice of different strains."
02/01/1965 - "[REGENERATION OF THE NERVE FIBERS, AFTER RESECTION OF THE SCIATIC NERVE, IN TRANSPLANTS OF CELLS OF EHRLICH ASCITES TUMOR]."
01/01/1969 - "Demonstration of antibodies in rats in response to xenogeneic grafts of Ehrlich ascites tumor by the fluorescent antibody technique."
06/01/1981 - "Cyclohexamide treatment of recipient mice at various times in relation to an intravenous injection of Ehrlich ascites tumor cells alters the pattern of consequent "metastatic" disease as compared with the pattern in untreated, tumour-injected animals. "
07/01/1957 - "I. Vitality of irradiated Ehrlich ascites tumor cells in intravenous injection]."
07/01/2008 - "The tissue distribution study and tumor growth inhibition were performed after intravenous injection of nanoparticles in Ehrlich ascites tumor (EAT)-bearing mice. "
01/01/1979 - "The toxic effect was estimated by LD50; the carcinogenic one--by the action on Ehrlich ascites tumor; the anaphylactoid effect was evaluated by the degree of the arterial pressure fall, the development of bronchospasm and an increased blood histamine level in cats under intravenous injection of platinum salts. "